The Global Bruxism Treatment Market Growth Accelerated By Increased Demand For Non-Surgical Treatment
Bruxism is a condition that causes teeth grinding and jaw clenching during
sleep affecting millions of people globally. Night guards and other dental
appliances have emerged as popular non-surgical alternatives to treat bruxism.
They help in protecting teeth from excessive wear and damage caused due to
grinding and help relax the jaw muscles and reduce teeth clenching.
The global Bruxism Treatment
Market is estimated to be valued at US$
1403.76 Bn in 2024 and is expected
to exhibit a CAGR of 11% over the forecast period 2024-2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends: The increased demand for non-surgical bruxism treatment has
been a key trend fueling market growth over the recent years. Night guards and
mouthpieces made of thermoplastic materials are the most common type of dental
appliances used for bruxism management. They are effective, less invasive, and
affordable treatment options compared to Botox injections and other surgical
procedures. High patient acceptability coupled with technological advancements
in mouth guard fabrication making them more customized and comfortable are some
factors contributing to the increased demand. Manufacturers are also developing
anti-bruxism devices integrated with smart sensors that can monitor grinding
activity and provide feedback to users about their sleep habits, which is
further expected to augment market growth during the forecast period.
Segment Analysis
The global bruxism treatment market is dominated by the dental clinic sub
segment as majority of the patients prefer visiting dentists for diagnosis and
treatment of bruxism. Dental professionals can appropriately examine the
patients, determine the exact cause of teeth grinding and provide customized
treatment plans ranging from mouth guards, dental braces, medication etc. This
makes dental clinics a reliable option for bruxism treatment.
Key Takeaways
The global Bruxism
Treatment Market Growth is expected to witness high growth over the
forecast period of 2024 to 2031. Rapidly increasing prevalence of bruxism,
growing awareness about available treatment options and rising healthcare
expenditure are some of the major factors driving the market. The global
Bruxism Treatment Market is estimated to be valued at US$ 1403.76 Bn in 2024 and
is expected to exhibit a CAGR of 11% over the forecast period 2024-2031.
Regional analysis
North America is currently the largest and fastest growing regional market for
bruxism treatment. Higher Bruxism incidence, well-established healthcare
infrastructure and high disposable incomes in countries like the US and Canada
are supporting the growth of bruxism treatment market in North America. Europe
is also emerging as a major regional market owing to growing adoption of
occlusal splints and mouth guards for bruxism management.
Key players
Key players operating in the bruxism treatment market are Siemens, Pfizer Inc.,
Ipsen Biopharmaceuticals, Henry Schein, Sanofi, Akervall Technologies Inc.,
PLANMECA OY, Merz Pharma GmbH & Co. KGaA, and Carestream Dental LLC.
Siemens offers a wide range of dental imaging systems like cone beam computed
tomography solutions that aid in accurate diagnosis and treatment planning for
bruxism. Pfizer provides various pharmacological products for bruxism treatment
including muscle relaxants and antidepressants.
Explore more related articles on this topic: https://www.ukwebwire.com/the-global-bruxism-treatment-market-growth/
Explore more related
articles: https://ceocolumn.com/blog/emergence-of-unmanned-combat-aerial-vehicles-in-modern-warfare/
https://blogger-veritas.blogspot.com/2024/01/the-global-bioinformatics-market-growth.html

Comments
Post a Comment